BioLineRx Ltd. (BLRX) Financials

$5.25

$1.46 (38.49%)
Last update: 04:00 PM EST
Day's range
$4.9
Day's range
$7.77
$40M$40M$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80MEarning201820182019201920202020202120212022202220232023202420240%0%-500%-500%-1000%-1000%-1500%-1500%-2000%-2000%-2500%-2500%-3000%-3000%Profit Margin
Profit Margin
Revenue
Earnings

BLRX Income statement / Annual

Last year (2024), BioLineRx Ltd.'s total revenue was $28.94 M, an increase of 502.92% from the previous year. In 2024, BioLineRx Ltd.'s net income was -$9.22 M. See BioLineRx Ltd.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $28.94 M $4.80 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $9.26 M $3.69 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $19.68 M $1.11 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0.68 0.23 0 0 0 0 0 0 0 0
Research and Development Expenses $9.15 M $12.52 M $17.63 M $19.47 M $18.17 M $23.44 M $19.81 M $19.51 M $11.18 M $11.49 M
General & Administrative Expenses $18.46 M $16.64 M $5.07 M $4.27 M $3.84 M $3.74 M $4.41 M $4.04 M $3.95 M $3.65 M
Selling & Marketing Expenses $10.08 M $14.59 M $6.46 M $1.00 M $840,000.00 $857,000.00 $1.36 M $1.69 M $1.35 M $1.00 M
Selling, General & Administrative Expenses $28.54 M $31.23 M $11.53 M $5.27 M $4.68 M $4.60 M $5.77 M $5.73 M $5.31 M $4.65 M
Other Expenses $2.40 M $7.05 M $5.67 M $42,000.00 $70,000.00 $78,000.00 $154,000.00 -$260,000.00 $7,000.00 $153,000.00
Operating Expenses $40.09 M $50.80 M $29.16 M $24.78 M $22.93 M $28.11 M $25.61 M $25.24 M $16.51 M $16.20 M
Cost And Expenses $49.35 M $54.49 M $29.16 M $24.78 M $22.93 M $28.11 M $25.61 M $25.24 M $16.51 M $16.20 M
Interest Income $1.82 M $2.01 M $694,000.00 $559,000.00 $236,000.00 $777,000.00 $719,000.00 $1.17 M $480,000.00 $457,000.00
Interest Expense $9.07 M $2.14 M $2.16 M $984,000.00 $1.47 M $1.83 M $21,000.00 $21,000.00 $14,000.00 $15,000.00
Depreciation & Amortization $4.07 M $1.38 M $654,000.00 $703,000.00 $934,000.00 $940,000.00 $451,000.00 $438,000.00 $454,000.00 $441,000.00
EBITDA $3.92 M -$57.09 M -$28.50 M -$24.07 M -$22.34 M -$26.89 M -$26.85 M -$23.85 M -$16.23 M -$15.77 M
EBITDA Ratio 0.14 -11.89 0 0 0 0 0 0 0 0
Operating Income Ratio -0.71 -10.35 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net $11.19 M -$10.92 M $4.21 M -$2.28 M -$7.09 M $2.67 M $2.64 M $888,000.00 $672,000.00 $1.80 M
Income Before Tax -$9.22 M -$60.61 M -$24.95 M -$27.05 M -$30.02 M -$25.45 M -$22.96 M -$24.35 M -$15.84 M -$14.40 M
Income Before Tax Ratio -0.32 -12.63 0 0 0 0 0 0 0 0
Income Tax Expense $0.00 $0.00 -$4.21 M $1.09 M $911,000.00 $1.36 M $2.66 M -$239,000.00 -$665,000.00 -$1.64 M
Net Income -$9.22 M -$60.61 M -$20.75 M -$28.14 M -$30.93 M -$26.81 M -$22.96 M -$24.35 M -$15.84 M -$14.40 M
Net Income Ratio -0.32 -12.63 0 0 0 0 0 0 0 0
EPS -0.12 -0.94 -0.4 -0.64 -1.8 -2.7 -3.15 -4.05 -4.2 -4.2
EPS Diluted -0.12 -0.94 -0.4 -0.64 -1.8 -2.7 -3.15 -4.05 -4.2 -4.2
Weighted Average Shares Out $79.87 M $64.22 M $51.60 M $44.20 M $16.86 M $9.76 M $7.24 M $6.00 M $3.74 M $3.43 M
Weighted Average Shares Out Diluted $79.87 M $64.22 M $51.60 M $44.20 M $16.86 M $9.76 M $7.24 M $6.00 M $3.74 M $3.43 M
Link